🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To investigate safety, tolerability, pharmacokinetics and pharmacodynamics ...
Status
Completed
Location
Multiple Locations
Start Date
2007-04
Trial ID
NCT02259959
The primary objective of this study is to assess the safety of 52 weeks onc...
Status
Completed
Location
1237.22.81015 Boehringer Ingelheim Investigational Site
Start Date
2012-02
Trial ID
NCT01536262
Treatments Being Tested
The primary objective of this study is to determine the optimum dose(s) of ...
Status
Completed
Location
1237.9.00152 Boehringer Ingelheim Investigational Site
Start Date
2008-07
Trial ID
NCT00720499
Treatments Being Tested
The objective of this study is to assess the efficacy and safety of 12 week...
Status
Completed
Location
1237.26.10620 Boehringer Ingelheim Investigational Site
Start Date
2013-11
Trial ID
NCT02006732
Treatments Being Tested
The overall objective is to assess the effect of once daily tiotropium + ol...
Status
Completed
Location
1237.19.10039 Boehringer Ingelheim Investigational Site
Start Date
2015-01-13
Trial ID
NCT02296138
Treatments Being Tested
The overall objective of this study is to assess the efficacy and safety of...
Status
Completed
Location
1237.5.01038 Boehringer Ingelheim Investigational Site
Start Date
2011-09
Trial ID
NCT01431274
Treatments Being Tested
The primary objective of this study is to determine the optimum dose(s) of ...
Status
Completed
Location
1237.4.0118 Boehringer Ingelheim Investigational Site
Start Date
2008-06
Trial ID
NCT00696020
Treatments Being Tested
Asthma is a common, chronic respiratory disease affecting 1-18 percent of t...
Status
Withdrawn
Location
Multiple Locations
Start Date
2019-01-18
Trial ID
NCT03376932
The primary objective of this study is to compare the effects of orally inh...
Status
Completed
Location
1237.15.01503 Boehringer Ingelheim Investigational Site
Start Date
2012-02
Trial ID
NCT01525615
The objective of this study is to assess the efficacy and safety of 12 week...
Status
Completed
Location
1237.25.10504 Boehringer Ingelheim Investigational Site
Start Date
2013-11
Trial ID
NCT01964352
Treatments Being Tested